These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11815970)

  • 1. Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors.
    Tokumura A; Tominaga K; Yasuda K; Kanzaki H; Kogure K; Fukuzawa K
    Cancer; 2002 Jan; 94(1):141-51. PubMed ID: 11815970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity.
    Tokumura A; Kume T; Fukuzawa K; Tahara M; Tasaka K; Aoki J; Arai H; Yasuda K; Kanzaki H
    Life Sci; 2007 Apr; 80(18):1641-9. PubMed ID: 17367815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy.
    Tokumura A; Kanaya Y; Miyake M; Yamano S; Irahara M; Fukuzawa K
    Biol Reprod; 2002 Nov; 67(5):1386-92. PubMed ID: 12390867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of plasma levels of lysophosphatidic acid in response to fasting of rats.
    Ino M; Shimizu Y; Tanaka T; Tokumura A
    Biol Pharm Bull; 2012; 35(11):2059-63. PubMed ID: 23123475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity.
    Hosogaya S; Yatomi Y; Nakamura K; Ohkawa R; Okubo S; Yokota H; Ohta M; Yamazaki H; Koike T; Ozaki Y
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):364-8. PubMed ID: 18583620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis.
    Tokumura A; Carbone LD; Yoshioka Y; Morishige J; Kikuchi M; Postlethwaite A; Watsky MA
    Int J Med Sci; 2009 Jun; 6(4):168-76. PubMed ID: 19521548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids.
    Tokumura A
    Biochim Biophys Acta; 2002 May; 1582(1-3):18-25. PubMed ID: 12069806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats.
    Tokumura A; Fujimoto H; Yoshimoto O; Nishioka Y; Miyake M; Fukuzawa K
    Life Sci; 1999; 65(3):245-53. PubMed ID: 10447209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered plasma levels of lysophospholipids in response to adrenalectomy of rats.
    Tsutsumi T; Ino M; Shimizu Y; Kawabata K; Nishi H; Tokumura A
    Prostaglandins Other Lipid Mediat; 2021 Oct; 156():106579. PubMed ID: 34245896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.
    Xu Y; Shen Z; Wiper DW; Wu M; Morton RE; Elson P; Kennedy AW; Belinson J; Markman M; Casey G
    JAMA; 1998 Aug; 280(8):719-23. PubMed ID: 9728644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer.
    Sedláková I; Vávrová J; Tošner J; Hanousek L
    Tumour Biol; 2011 Apr; 32(2):311-6. PubMed ID: 21061112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum autotaxin is not a useful biomarker for ovarian cancer.
    Nakamura K; Igarashi K; Ohkawa R; Yokota H; Masuda A; Nakagawa S; Yano T; Ikeda H; Aoki J; Yatomi Y
    Lipids; 2012 Sep; 47(9):927-30. PubMed ID: 22700442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid: an ovarian cancer marker.
    Sedláková I; Vávrová J; Tosner J; Hanousek L
    Eur J Gynaecol Oncol; 2008; 29(5):511-4. PubMed ID: 19051824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
    Shen Z; Wu M; Elson P; Kennedy AW; Belinson J; Casey G; Xu Y
    Gynecol Oncol; 2001 Oct; 83(1):25-30. PubMed ID: 11585410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of serum lysophosphatidic acid as a potential biomarker for ovarian cancer.
    Meleh M; Pozlep B; Mlakar A; Meden-Vrtovec H; Zupancic-Kralj L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):287-91. PubMed ID: 17766199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lysophosphatidic acid in the management of benign and malignant ovarian tumors.
    Pozlep B; Meleh M; Kobal B; Verdenik I; Osredkar J; Kralj LZ; Meden-Vrtovec H
    Eur J Gynaecol Oncol; 2007; 28(5):394-9. PubMed ID: 17966220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits.
    Tokumura A; Kanaya Y; Kitahara M; Miyake M; Yoshioka Y; Fukuzawa K
    J Lipid Res; 2002 Feb; 43(2):307-15. PubMed ID: 11861673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophospholipids are potential biomarkers of ovarian cancer.
    Sutphen R; Xu Y; Wilbanks GD; Fiorica J; Grendys EC; LaPolla JP; Arango H; Hoffman MS; Martino M; Wakeley K; Griffin D; Blanco RW; Cantor AB; Xiao YJ; Krischer JP
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1185-91. PubMed ID: 15247129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid production from lysophosphatidylcholine by lysophospholipase D activity of autotaxin in plasma of women with normal and adverse pregnancies.
    Tsutsumi T; Yasuda K; Neya M; Okada H; Tokumura A
    Prostaglandins Other Lipid Mediat; 2022 Dec; 163():106670. PubMed ID: 35963509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lysophosphatidic acid in ovarian cancer patients].
    Sedlákova I; Vávrová J; Tosner J; Hanousek L
    Ceska Gynekol; 2006 Jul; 71(4):312-7. PubMed ID: 16956044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.